Transitional Drugs 7

NHS Wales Shared Services Partnership - Procurement Services (hosted by Velindre NHS Trust)

Publication date 10 April 2026, 11:50am
Contract locations
UKL22 - Cardiff and Vale of Glamorgan
UKL - Wales
Lot value
£53,566,932
Total value £53,566,932

The provision of Drugs which have lost or are shortly to lose exclusivity, namely Eculizumab; Icatibant; Nintedanib; Omalizumab; Tocilizumab

Transitional Drugs 7